TRACON Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 17

Employees

  • Stock Symbol
  • TCON

Stock Symbol

  • Share Price
  • $1.49
  • (As of Friday Closing)

TRACON Pharmaceuticals General Information

Description

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.

Contact Information

Formerly Known As
Lexington Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Corporate Office
  • 4350 La Jolla Village Drive
  • Suite 800
  • San Diego, CA 92122
  • United States
+1 (858) 000-0000

TRACON Pharmaceuticals Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TRACON Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.49 $1.52 $1.41 - $14.75 $3.99M 2.68M 266K -$24.40

TRACON Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 11,230 (2,310) 25,153 26,043
Revenue 12,145 12,045 0 346
EBITDA 7,842 3,750 (28,071) (28,349)
Net Income 1,748 (3,588) (29,135) (28,667)
Total Assets 9,355 10,105 19,469 26,557
Total Debt 0 236 10,005 1,538
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TRACON Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request a free trial

TRACON Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request a free trial

TRACON Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targ
Drug Discovery
San Diego, CA
17 As of 2023
00000
000000000 00000

00000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000000
Hayward, CA
000 As of 0000
00.000
000000000 00.000

000000

t enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
000000000000000
Rockville, MD
0 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TRACON Pharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arcus Biosciences Formerly VC-backed Hayward, CA 000 00.000 000000000 00.000
Regenerx Formerly VC-backed Rockville, MD 0 000.00 000000000 000.00
iQone Corporate Backed or Acquired Versoix, Switzerland 00 000000&0
Vicore Pharma Holding Formerly VC-backed Stockholm, Sweden 00 00000 000000000 00000
Harmony Biosciences Formerly VC-backed Plymouth Meeting, PA 000 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

TRACON Pharmaceuticals Patents

TRACON Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015346444-A1 Anti-endoglin antibodies and uses thereof Inactive 12-Nov-2014 00000000000
CA-2966905-A1 Anti-endoglin antibodies and uses thereof Inactive 12-Nov-2014 00000000000
JP-2018076350-A Antibody formulations and uses thereof Active 05-Sep-2012 0000000000 0
JP-2019059753-A Antibody formulations and uses thereof Active 05-Sep-2012 000000000 0
AU-2013312536-A1 Antibody formulations and uses thereof Active 05-Sep-2012 A61K47/22
To view TRACON Pharmaceuticals’s complete patent history, request access »

TRACON Pharmaceuticals Executive Team (13)

Name Title Board Seat Contact Info
Charles Theuer MD Chief Executive Officer & Chairman
Scott Brown Chief Financial Officer
Mark Wiggins Chief Business Officer
Shahe Garabedian Senior Vice President, Quality Assurance
James Freddo MD Chief Medical Officer
You’re viewing 5 of 13 executive team members. Get the full list »

TRACON Pharmaceuticals Board Members (17)

Name Representing Role Since
Carol Lam TRACON Pharmaceuticals Board Member 000 0000
Charles Theuer MD TRACON Pharmaceuticals Chief Executive Officer & Chairman 000 0000
J. Twiford Ph.D Brookline Group Board Member 000 0000
Lisa Johnson-Pratt TRACON Pharmaceuticals Board Member 000 0000
Martin Mattingly Ph.D TRACON Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

TRACON Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TRACON Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request a free trial

TRACON Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view TRACON Pharmaceuticals’s complete esg history, request access »

TRACON Pharmaceuticals FAQs

  • When was TRACON Pharmaceuticals founded?

    TRACON Pharmaceuticals was founded in 2004.

  • Who is the CEO of TRACON Pharmaceuticals?

    Charles Theuer MD is the CEO of TRACON Pharmaceuticals.

  • Where is TRACON Pharmaceuticals headquartered?

    TRACON Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of TRACON Pharmaceuticals?

    TRACON Pharmaceuticals has 17 total employees.

  • What industry is TRACON Pharmaceuticals in?

    TRACON Pharmaceuticals’s primary industry is Drug Discovery.

  • Is TRACON Pharmaceuticals a private or public company?

    TRACON Pharmaceuticals is a Public company.

  • What is TRACON Pharmaceuticals’s stock symbol?

    The ticker symbol for TRACON Pharmaceuticals is TCON.

  • What is the current stock price of TRACON Pharmaceuticals?

    As of 24-May-2024 the stock price of TRACON Pharmaceuticals is $1.49.

  • What is the current market cap of TRACON Pharmaceuticals?

    The current market capitalization of TRACON Pharmaceuticals is $3.99M.

  • What is TRACON Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for TRACON Pharmaceuticals is $12.1M.

  • Who are TRACON Pharmaceuticals’s competitors?

    Arcus Biosciences, Regenerx, iQone, Vicore Pharma Holding, and Harmony Biosciences are some of the 8 competitors of TRACON Pharmaceuticals.

  • What is TRACON Pharmaceuticals’s annual earnings per share (EPS)?

    TRACON Pharmaceuticals’s EPS for 12 months was -$24.40.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »